Not available
Quote | Pharmaxis Ltd ADR (OTCMKTS:PXSLY)
Last: | $0.88 |
---|---|
Change Percent: | -7.37% |
Open: | $0.88 |
Close: | $0.88 |
High: | $0.88 |
Low: | $0.88 |
Volume: | 582 |
Last Trade Date Time: | 05/21/2021 04:42:18 am |
News | Pharmaxis Ltd ADR (OTCMKTS:PXSLY)
Melbourne, Australia (ABN Newswire) - BTC Health Limited (ASX:BTC) is pleased to announce its investee company, BioImpact Pty Ltd, has acquired exclusive distribution rights for specialty respiratory brands Bronchitol(R) and Aridol(R) from Pharmaxis (ASX:PXS) in Australia, New Zealand, Singap...
Galecto has filed proposed terms for an $85 million U.S. IPO. The firm is development treatments for various fibrosis diseases. GLTO has produced impressive trial results to-date. For life science investors with a long-term hold time frame, the IPO is worth considering. ...
Message Board Posts | Pharmaxis Ltd ADR (OTCMKTS:PXSLY)
Subject | By | Source | When |
---|---|---|---|
PXSLY ADR program terminated. FINRA deleted symbol: | Renee | investorshub | 06/07/2021 9:24:32 PM |
$PXSLY recent news/filings | stocktrademan | investorshub | 07/23/2015 7:29:23 PM |
chartguy89: PXSLY 1.39 Stock Charts $PXSLY 1 Month Chart | chartguy89 | investorshangout | 03/09/2014 2:55:52 PM |
chartguy89: PXSLY Stock Charts Last: -0.29 Saturday, March 1, 2014 at 5:56:45 AM $PXSLY 1 Mo | chartguy89 | investorshangout | 03/01/2014 10:56:59 AM |
News, Short Squeeze, Breakout and More Instantly...
Pharmaxis Ltd ADR Company Name:
PXSLY Stock Symbol:
OTCMKTS Market:
Melbourne, Australia (ABN Newswire) - BTC Health Limited (ASX:BTC) is pleased to announce its investee company, BioImpact Pty Ltd, has acquired exclusive distribution rights for specialty respiratory brands Bronchitol(R) and Aridol(R) from Pharmaxis (ASX:PXS) in Australia, New Zealand, Singap...
LONDON , November 15, 2018 /PRNewswire/ -- Arix Bioscience plc ("Arix") (LSE: ARIX), a global healthcare and life science company supporting medical innovation, is pleased to note that Pharmaxis Ltd (ASX: PXS), an Australian pharmaceutical research company focused on inflammation and fi...
LONDON , October 11, 2018 /PRNewswire/ -- Arix Bioscience plc ("Arix") (LSE: ARIX), a global healthcare and life science company supporting medical innovation, is pleased to note that its Group Business, Pharmaxis Ltd (ASX: PXS), an Australian pharmaceutical research company focused on ...